GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XSpray Pharma AB (STU:6XP) » Definitions » Shiller PE Ratio

XSpray Pharma AB (STU:6XP) Shiller PE Ratio : (As of May. 02, 2025)


View and export this data going back to 2018. Start your Free Trial

What is XSpray Pharma AB Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


XSpray Pharma AB Shiller PE Ratio Historical Data

The historical data trend for XSpray Pharma AB's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XSpray Pharma AB Shiller PE Ratio Chart

XSpray Pharma AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

XSpray Pharma AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of XSpray Pharma AB's Shiller PE Ratio

For the Biotechnology subindustry, XSpray Pharma AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


XSpray Pharma AB's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, XSpray Pharma AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where XSpray Pharma AB's Shiller PE Ratio falls into.


;
;

XSpray Pharma AB Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

XSpray Pharma AB's E10 for the fiscal year that ended in Dec24 is calculated as:

For example, XSpray Pharma AB's adjusted earnings per share data for the fiscal year that ended in Dec24 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec24 (Change)*Current CPI (Dec24)
=-0.749/132.9872*132.9872
=-0.749

Current CPI (Dec24) = 132.9872.

XSpray Pharma AB Annual Data

Earnings per Share (Diluted) CPI Adj_EPS
201512 -0.104 100.276 -0.138
201612 -0.065 102.022 -0.085
201712 -0.172 103.793 -0.220
201812 -0.162 105.912 -0.203
201912 -0.281 107.766 -0.347
202012 -0.294 108.296 -0.361
202112 -0.480 112.486 -0.567
202212 -0.562 126.365 -0.591
202312 -0.604 131.912 -0.609
202412 -0.749 132.987 -0.749

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


XSpray Pharma AB  (STU:6XP) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


XSpray Pharma AB Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of XSpray Pharma AB's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


XSpray Pharma AB Business Description

Traded in Other Exchanges
Address
Scheeles vag 2, Solna, SWE, SE-171 65
XSpray Pharma AB is a pharmaceutical company focused on developing improved PKIs for cancer treatment, leveraging its proprietary HyNap technology platform. The company aims to enhance clinical outcomes for cancer patients by improving the efficacy, safety, and patient experience of existing cancer therapies. Its product portfolio includes Dasynoc and other product candidates in different stages of development such as XS003 nilotinib, XS008 axitinib, and other.

XSpray Pharma AB Headlines

No Headlines